An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the safety and efficacy of HS-20137 in the treatment of participants with moderate-to-severe plaque psoriasis
Epistemonikos ID: 0cfdcb5c874e814a793cefd77cf53a4d4bef390d
First added on: Oct 20, 2026